Stephanie Pilat, PharmD

home / authors / stephanie-pilat-pharmd

Articles

SergeVo - stock.adobe.com

What’s Ahead in the Adalimumab Biosimilar Pipeline in Dermatology

Stephanie Pilat, PharmD;Viktoriya Avlasevich, PharmD;Lisa Cristofaro, PharmD, BS, BCACP
July 17th 2023

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.

Read More

HSSP Leads to High Rate of Acid Suppression Therapy Substitution

HSSP Leads to High Rate of Acid Suppression Therapy Substitution

Stephanie Pilat, PharmD;Kendra R. Delibert, PHARMD, BCOP;Andrea M. Baran, MS;Jeremiah Moore, PharmD, BCOP
September 20th 2022

This study highlights one benefit of the integrated health system specialty pharmacy model for patients who are prescribed acalabrutinib.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD